Publicaciones relevantes
1. Zuniga‑Guajardo S, Jimenez J, Angel A, Zinman B. Effects of massive obesity on
insulin sensitivity, insulin clearance and the metabolic responses to insulin as
assessed by the glucose clamp technique. 1986 Metabolism 35:276‑282.
2. Jimenez J, Zuniga‑Guajardo S, Zinman B, Angel A. Effects of weight loss in massive
obesity on insulin and C‑peptide dynamics: sequential changes in insulin production,
clearance, and sensitivity. 1987 J Clin Endocrinol Metab 64:661‑668.
3. Salter A, Fong B, Jimenez J, Rotstein L, Angel A. Regional variation in high density
lipoprotein binding to human adipocyte plasma membranes of massively obese
subjects. 1987 Eur J Clin Invest 17: 16‑22.
4. Despres JP, Fong B, Julien P, Jimenez J, Angel A. Regional variation in HDL
metabolism in human fat cells: effect of cell size. 1987 Am J Physiol 252:E654‑E659.
5. Fong B, Salter AM, Jimenez J, Angel A. The role of apolipoprotein A I and
apolipoprotein A II in high-density lipoprotein binding to adipocyte plasma
membranes. 1987 Biochem Biophys Acta 292:105‑113.
6. Jiménez J, Fong B, Julien P, Despres JP, Angel A. Weight loss in massive obesity:
reciprocal changes in plasma HDL cholesterol and HDL binding to human adipocyte
plasma membranes. 1988 Metabolism 37: 580‑587.
7. Jimenez J, Fong B, Julien P, Després JP, Angel A. Effect of obesity on low and high
density lipoprotein binding to human adipocyte plasma membranes. 1989 Int J
Obesity 13:699‑709.
8. Mora‑Morales E., Keith P., Jiménez J.G. Chronic disease in Costa Rica. Information
on diabetes mellitus. 1990 BulletinIDF 35:58‑59
9. Jiménez J.G., Arauz A.G., Vargas M.A. Effect of a lipid lowering diet on serum lipid
and lipoprotein concentration in hypercholesterolemic females. Cardiología
Intercontinental 1997 (6) 1:3-8.
10. Grossman D.W.; Knox J.J.; Nash C.; Jiménez J.G. Smoking: attitudes of Costa
Rican physicians. Bulletin of the World Health Organization. 1999, 77(4): 315-322.
11. Jiménez JG. Protective factors aganist ischemic heart disease in familial
hypercholesterolemia. Cardiología Intercontinental 1999.
12. Jiménez JG; Lobo Hernández E.; Picado A; Molina Marco. Secondary
hyperparathyroidism after removal of a parathyroid adenoma. Endocrine Practice
2002, 8(6):429-432.
13. Rosen JB; Jiménez JG; Pirags V; Vides H; Hanson M; Massaad R; McPeters G;
Joseph Triscari J; Brudi P. A Comparison of Switching to Ezetimibe/Simvastatin (10
mg/20 mg) versus Doubling the Statin Dose to Simvastatin 40 mg or Atorvastatin 20
mg or Switching to Rosuvastatin 10 mg in Patients with Cardiovascular Disease and
Diabetes Mellitus. Diab Vasc Dis Res 2013 Jan 3. Rosen et al. Lipids in Health and
Disease 2013, 12:103 http://www.lipidworld.com/content/12/1/103
14. Jiménez JG, Rosen JB, Pigras V, Massad R, Handson ME, Brudi P, Triscari J. The
efficacy and safety of ezetimebe/simvastatin combination compared with intensified
lipid-lowerin treatment strategies in diabetic subjects with and without metabolic
síndrome. Diabetes, Obesity and Metabolism 2013;15(6):513-1522.
15. Jiménez-Montero JG, Gregory Haft. Simvastatin/fenofibrate combination in the
treatment of dyslipidemia: current evidence. Research and Reports in Endocrine
Disorders. 2015:5 1–13.
16. Gamboa-Gamboa T, Abarca-Soto G, Jiménez-Montero JG. Prevalence of 25
hydroxyvitamin D deficiency in healthy people in the Metropolitan Area in Costa Rica.
Research and Reports in Endocrine Disorders. 2015:5 135–140.
17. Jiménez.Montero JG Pos-Delivery Hypoglycemia in Type 1 Diabetic Patient is
Associated with Lactation: A Case Presentation. http://dx.doi.org/10.18689/MJD1102
18. Mechanick JI, Harrel RM, Allende-Vigo M, et al. AACE/ACE Transculturalization
Recommendations for Developing Latin American Clinical Practice Algorithms in
Endocrinology-Proceedings of the 2015 Pan-American Workshop by the American
Association of Clinical Endocrinologists and American College of Endocrinology.
Endocrine Practice 2016: 2:476-501.
19. Jiménez-Montero, JG; Mora-Aguilar; Chen-Ku Chih. Diabetic Ketoacidosis in a
Patient with Type 1 Diabetes Mellitus Treated with Low Insulin Doses in Combination
with Empagliflozin. AACE Clinical Case Rep. 2018;4(No. 6).
20. Jiménez-Montero, JG, Moya-Sancho E, Brenes-Pino F, Crespo-Sáenz A, Rivera
Aguerri A. Resistant hypertension in a patient with Primary Aldosteronism due to a
suprarenal adenoma. AMC 2019 (No.2, vol 61)
21. Jiménez-Montero, JG. Diabetic Ketoacidosis Linked with Sodium Glucose Co
Transporter 2 Inhibitors in an Elderly Patient with Type 2 Diabetes. Int J Endocrinol
Metab Disord. 2019 5(1): dx.doi.org/10.16966/2380-548X.154
22. Jiménez-Montero JG, Hernández-Saborío I, Cob-Sánchez A. Severe Hypoglycemia
in an Emergency Department of a General Hospital in Costa Rica. Diabetes & it´s
Complications. 2019; 3(2): 1-5.
23. Jiménez-Montero JG, Cerdas-Perez S, Ruiz-Salazar F, Yung-Li G, Ulate-Oviedo L,
Jiménez-Navarrete M, Calvo-Marin J, Alvayero C and Palencia J. Diabetes Ketoacidosis
Linked to Inhibitors of Sodium Glucose Co-Transporters in Diabetic Patients in Central
America. Annals of Clinical Diabetes and Endocrinology. 2020; (3):1-5.
24. Jimenez-Montero JG, Briceño L. Diabetic Ketoacidosis, Lactic Acidosis and
Alcoholic Acidosis in a Type 2 Diabetic Male: Synergic Effects of SGLT-2 Inhibitors with
Heavy Alcohol Consumption Int J Clin Med Cases Volume: 3.5 2020.
25. Jiménez-Montero JG, Villegas-Barakat M, Cerdas-Salas O. Coto-Hernandez M,
Sancho-Ugalde H, MD, Covid-19 in Costa Rica: Achieved goals and imminent risks. Int
J Biomed Res Prac, 2020 Volume 1 | Issue 1 | 1 of 4.
26. Jiménez-Montero JG, Carvajal-Solorzano ML, Villegas-Barakat M. Reduction of Recurrent Severe Hypoglycemia and Hypoglycemia Unawareness in Type 2 Diabetes
by Treatment Modification and Diabetes Education. Diabetes & its Complications
2020; 4(2); 1-7.
27. Jiménez-Montero JG, Villegas-Barakat M. Diabetes Mortality in Costa Rica 2007
2017. Diabetes Research and Clinical Practice. 2021;174:108749.
28. Villegas-Barakat ML, Jiménez-Montero JG. Análisis provincial de la mortalidad por diabetes en Costa Rica. 2007-2017. Rev ALAD 2021; 110-7.
29. Jimenez-Montero JG,Villegas-Barakat ML. Diabetes Remission in a Young Patient
with No-Alcoholic Liver Disease. Annals of Clinical Nutrition 2023 6(2) 2029.
Capitulos en libros
1. Fong B, Salter AM, Jiménez J, Despres JP, Angel A. HDL binding to human
adipocyte plasma membranes: regional variation in omental and subcutaneous
depots. 1986. In Lipoprotein Deficiency Syndromes. Angel and Frollich editors.
Plenum Publishing Corporation.
2. Angel A, Jiménez J, Despres JP, Julien P, Zsigmond E, Fong B. Effects of obesity
and fat cell size on lipoprotein binding to human adipocytes. 1987 Berry EM,
Blondheim SH, Eliahou HE, Shafrir E. Editors John Libbey & Company Ltd.
3. José G. Jiménez-Montero. How diabetes has been organized in Costa Rica.
Diabetes 1994. Elsevier Science, S. Baba and T. Kaneko, editors.
Otras publicaciones:
1. Quesada Chaves D, Coto Yglesias F, Gonzalez Volio M, Herrera Martinez,
Herrera Peraza, Jimenez Montero, Obando Vega, Ortiz Vargas, Ulate Retana, Ruiz
Salazar, Spencer Melendez, Zuñiga Kondrashva, Zúñiga Solano. Primer consenso
Costarricense para el Manejo Integral de la Diabetes Mellitus 2022.
